Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Clin Neurophysiol ; 132(11): 2751-2762, 2021 11.
Article in English | MEDLINE | ID: mdl-34583117

ABSTRACT

OBJECTIVE: To examine the hypothesis that small vessel disease disrupts postural networks in older adults with unexplained dizziness in the elderly (UDE). METHODS: Simultaneous electroencephalography and postural sway measurements were undertaken in upright, eyes closed standing, and sitting postures (as baseline) in 19 younger adults, 33 older controls and 36 older patients with UDE. Older adults underwent magnetic resonance imaging to determine whole brain white matter hyperintensity volumes, a measure of small vessel disease. Linear regression was used to estimate the effect of instability on electroencephalographic power and connectivity. RESULTS: Ageing increased theta and alpha desynchronisation on standing. In older controls, delta and gamma power increased, and theta and alpha power reduced with instability. Dizzy older patients had higher white matter hyperintensity volumes and more theta desynchronisation during periods of instability. White matter hyperintensity volume and delta power during periods of instability were correlated, positively in controls but negatively in dizzy older patients. Delta power correlated with subjective dizziness and instability. CONCLUSIONS: Neural resource demands of postural control increase with age, particularly in patients with UDE, driven by small vessel disease. SIGNIFICANCE: EEG correlates of postural control saturate in older adults with UDE, offering a neuro-physiological basis to this common syndrome.


Subject(s)
Aging/physiology , Brain/physiology , Cerebral Small Vessel Diseases/physiopathology , Dizziness/physiopathology , Electroencephalography/methods , Postural Balance/physiology , Adult , Aged , Aged, 80 and over , Brain/diagnostic imaging , Brain Waves/physiology , Cerebral Small Vessel Diseases/diagnostic imaging , Dizziness/diagnostic imaging , Female , Humans , Male , Middle Aged , Nerve Net/diagnostic imaging , Nerve Net/physiology , Standing Position , Young Adult
2.
J Neurovirol ; 25(1): 9-21, 2019 02.
Article in English | MEDLINE | ID: mdl-30298203

ABSTRACT

It is yet unclear if people infected with human immunodeficiency virus (HIV+) on stable, combined antiretroviral therapies (cARTs) decline with age at the same or greater rate than healthy people. In this study, we examined independent and interactive effects of HIV, age, and HIV-related clinical parameters on neuropsychological functioning and brain regional volume in a sizable group of Polish HIV+ men receiving cART. We also estimated the impact of nadir CD4 cell count, CD4 cell count during participation in the study, duration of HIV infection, or duration of cART along with age. Ninety-one HIV+ and 95 control (HIV-) volunteers ages 23-75 completed a battery of neuropsychological tests, and 54 HIV+ and 62 HIV- of these volunteers participated in a brain imaging assessment. Regional brain volume in the cortical and subcortical regions was measured using voxel-based morphometry. We have found that HIV and older age were independently related to lower attention, working memory, nonverbal fluency, and visuomotor dexterity. Older age but not HIV was associated with less volume in several cortical and subcortical brain regions. In the oldest HIV+ participants, age had a moderating effect on the relationship between the duration of cART and visuomotor performance, such as that older age decreased speed of visuomotor performance along with every year on cART. Such results may reflect the efficacy of cART in preventing HIV-associated brain damage. They also highlight the importance of monitoring neuropsychological functioning and brain structure in HIV+ patients. This is particularly important in older patients with long adherence to cART.


Subject(s)
Anti-HIV Agents/therapeutic use , Cerebral Cortex/physiopathology , HIV Infections/physiopathology , Adult , Age Factors , Aged , Antiretroviral Therapy, Highly Active , CD4 Lymphocyte Count , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/virology , Case-Control Studies , Cerebral Cortex/diagnostic imaging , Cerebral Cortex/drug effects , Cerebral Cortex/virology , HIV Infections/diagnostic imaging , HIV Infections/drug therapy , HIV Infections/virology , Humans , Magnetic Resonance Imaging , Male , Memory, Short-Term/drug effects , Middle Aged , Neuroimaging , Neuropsychological Tests , Organ Size/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL